About Biocoat
Biocoat is a company based in Philadelphia (United States) founded in 1991 was acquired by GTCR in November 2022. Biocoat has completed 1 acquisition, including Chempilots. Biocoat offers products and services including Thermal Coating, UV Coating, Coating Services, and Custom Polymers. Biocoat operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Investors1315 Capital
& 1 more
- Investments & Acquisitions
- Acquired by
Products & Services of Biocoat
Biocoat offers a comprehensive portfolio of products and services, including Thermal Coating, UV Coating, Coating Services, and Custom Polymers.
Hydrophilic coating for medical devices using thermal curing.
Hydrophilic coating via UV curing for device applications.
Custom application and development for medical device coatings.
Synthesis of polymers for hydrophilic coating needs.
Apps and channels of Biocoat
its YouTube channel Biocoat Inc. has 27 subscribers and 17 videos.
Videos from Biocoat
The most watched videos on Biocoat's YouTube channel, Biocoat Inc. (27 subscribers). Click a video to play it here.
More on Biocoat Inc..
Investors in Biocoat
Biocoat has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include 1315 Capital and GTCR Chicago Private Equity Firm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Expansion and growth capital is provided by 1315 Capital to healthcare companies. | – | 1315capital.com | Philadelphia, United States | |
Private equity investments and firm management in Chicago. | – | gtcr.com | - |
Investor details for Biocoat
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biocoat
2 people are tracked at Biocoat (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Scott D'Amour | Chief Financial Officer | Leadership |
Jim Moran | Senior Advisor | Team |
Complete people profiles for Biocoat
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocoat
Biocoat has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Chempilots.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Contract-based polymer production for medical devices is provided. | chempilots.com | Farum, Denmark | 1957 | Jul 2023 | •••• |
Complete acquisition details for Biocoat
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Biocoat
4 dated milestones of Biocoat across 32 years, from founding to its latest funding, stage changes and deals.
- Founded Biocoat is founded.
- Exit Acquired by 1315 Capital.
- Exit Acquired by GTCR.
- Acquisition Acquires Chempilots.
Competitors of Biocoat
Biocoat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of Biocoat
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocoat
Complete news archive for Biocoat
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Biocoat
10 companies that operate in the same segment as Biocoat (Chemicals Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Microbe-based plant protection products and yield optimization services are provided. | 2013 | Boston, Massachusetts, United States | USD 1.4 B | – | – | |
Plant-based biopesticides are developed for agricultural applications by Terramera. | 2010 | Vancouver, British Columbia, Canada | USD 64.94 M | USD 3.42 M | 16 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
Developr of bio-based products and natural compounds for biotechnological solutions | 1993 | Zwingenberg, Hesse, Germany | USD 5.38 M | – | – | |
Sustainable bio-based chemicals are manufactured using a proprietary platform. | 2016 | Houston, Texas, United States | USD 686.05 M | – | – | |
Biological insecticides and pesticides are developed from spider peptides. | 2001 | Kalamazoo, Michigan, United States | USD 286.68 M | – | – | |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied. | 2010 | Berkeley, California, United States | USD 618.08 M | – | – | |
Instruments and software for color calibration are developed by Datacolor. | 1970 | Lawrenceville, United States | – | USD 781.59 K | 20 | |
Green acids are produced from microbes via synthetic biology. | 2010 | Emeryville, California, United States | USD 51.77 M | – | – | |
Phytochemicals are developed using microbial fermentation processes. | 2011 | Cambridge, Massachusetts, United States | USD 115.93 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biocoat
Biocoat was founded in 1991.
Biocoat is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Biocoat was founded in 1991 in Philadelphia, United States, and operates in the medical device sector. Hydrophilic coatings are provided through the Hydak technology platform, where polysaccharides like Hyaluronic acid are covalently bonded to device surfaces. This enables hydrogel behavior and lubricity for improved performance. The companys focus remains on coating solutions for various medical applications.
Biocoat's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Biocoat offers Thermal Coating, UV Coating, Coating Services, and Custom Polymers.
Biocoat has made 1 acquisition, including Chempilots.
Biocoat has 2 investors. Key investors include 1315 Capital, and GTCR Chicago Private Equity Firm.
Biocoat operates through Biocoat Incorporated.
Yes. Biocoat was acquired by GTCR in November 2022.